[Treatment of hyperlipoproteinemia]. 1978

G Creţeanu, and D Lacatîş

UI MeSH Term Description Entries
D006949 Hyperlipidemias Conditions with excess LIPIDS in the blood. Hyperlipemia,Hyperlipidemia,Lipemia,Lipidemia,Hyperlipemias,Lipemias,Lipidemias
D009539 Nicotinic Acids 2-, 3-, or 4-Pyridinecarboxylic acids. Pyridine derivatives substituted with a carboxy group at the 2-, 3-, or 4-position. The 3-carboxy derivative (NIACIN) is active as a vitamin. Acids, Nicotinic
D002792 Cholestyramine Resin A strongly basic anion exchange resin whose main constituent is polystyrene trimethylbenzylammonium Cl(-) anion. Cholestyramine,Colestyramine,Colestyramin,Cuemid,MK-135,Quantalan,Questran,Cholestyramine Resins,Cholestyramines,Colestyramines,Colestyramins,Cuemids,MK 135,MK135,Quantalans,Questrans,Resin, Cholestyramine,Resins, Cholestyramine
D002994 Clofibrate A fibric acid derivative used in the treatment of HYPERLIPOPROTEINEMIA TYPE III and severe HYPERTRIGLYCERIDEMIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p986) Athromidin,Atromid,Atromid S,Clofibric Acid, Ethyl Ester,Ethyl Chlorophenoxyisobutyrate,Miscleron,Miskleron,Chlorophenoxyisobutyrate, Ethyl
D004040 Dietary Carbohydrates Carbohydrates present in food comprising digestible sugars and starches and indigestible cellulose and other dietary fibers. The former are the major source of energy. The sugars are in beet and cane sugar, fruits, honey, sweet corn, corn syrup, milk and milk products, etc.; the starches are in cereal grains, legumes (FABACEAE), tubers, etc. (From Claudio & Lagua, Nutrition and Diet Therapy Dictionary, 3d ed, p32, p277) Carbohydrates, Dietary,Carbohydrate, Dietary,Dietary Carbohydrate
D004041 Dietary Fats Fats present in food, especially in animal products such as meat, meat products, butter, ghee. They are present in lower amounts in nuts, seeds, and avocados. Fats, Dietary,Dietary Fat,Fat, Dietary
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000434 Alcoholic Beverages Drinkable liquids containing ETHANOL. Alcoholic Beverage,Beverage, Alcoholic,Beverages, Alcoholic
D001645 Biguanides Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES. Biguanide

Related Publications

G Creţeanu, and D Lacatîş
September 1976, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
G Creţeanu, and D Lacatîş
December 1994, Nihon rinsho. Japanese journal of clinical medicine,
G Creţeanu, and D Lacatîş
February 1990, Wiener medizinische Wochenschrift (1946),
G Creţeanu, and D Lacatîş
July 1987, Soins; la revue de reference infirmiere,
G Creţeanu, and D Lacatîş
July 1987, Soins; la revue de reference infirmiere,
G Creţeanu, and D Lacatîş
January 1997, Anales de medicina interna (Madrid, Spain : 1984),
G Creţeanu, and D Lacatîş
January 1991, Khirurgiia,
G Creţeanu, and D Lacatîş
December 1971, Polskie Archiwum Medycyny Wewnetrznej,
G Creţeanu, and D Lacatîş
January 1998, Terapevticheskii arkhiv,
G Creţeanu, and D Lacatîş
February 1976, Polski tygodnik lekarski (Warsaw, Poland : 1960),
Copied contents to your clipboard!